Affymetrix (Santa Clara, California) (AFFX) Names GenoSplice as Its Preferred Data Analysis Service Provider Increasing Accessibility for Bioinformatics in Genomic Research
3/6/2013 10:10:52 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) announced a co-marketing agreement today naming GenoSplice, Inc. as its preferred data analysis service provider for the new GeneChip® Human Transcriptome Array 2.0, the most comprehensive microarray available for alternative splicing detection. GenoSplice, a leader in genomic data analysis and alternative splicing, has developed a dedicated expression analysis solution, EASANA®, including analysis for Affymetrix’ microarrays, such as GeneChip® Exon 1.0 ST Array, GeneChip® Human Transcriptome Array 1.0, and the new GeneChip® Human Transcriptome Array 2.0. When combined with GenoSplice analysis services, these arrays provide the highest resolution profiling of the transcriptome available on a microarray at both the gene and exon level.
comments powered by